Agents targeting the B7 family co-inhibitory receptors cytotoxic T-lymphocyte antigen-4 (CTLA-4) and programmed cell death protein-1 (PD-1), or its ligand (PD-L1), have a pivotal role in clinical practice. V-domain Ig suppressor of T-cell activation (VISTA) is a protein highly conserved between species, with a similar amino acid sequence to the...
-
2021 (v1)PublicationUploaded on: April 14, 2023
-
2024 (v1)Publication
IntroductionAnticancer treatments have significantly contributed to increasing cure rates of breast cancer in the last years; however, they can also lead to short- and long-term side effects, including gonadotoxicity, and compromised fertility in young women. Oncofertility is a crucial issue for young patients who have not yet completed their...
Uploaded on: October 13, 2024 -
2023 (v1)Publication
No description
Uploaded on: February 11, 2024 -
2022 (v1)Publication
Background and rationale Little is known about SARS-CoV-2 seroconversion in asymptomatic patients affected by solid cancer, and whether it is associated with specific transcriptomics changes in peripheral blood mononuclear cells (PBMC). Methods Patients affected by solid cancer treated in a top comprehensive cancer center in Italy during the...
Uploaded on: February 14, 2024 -
2022 (v1)Publication
The role of 2-deoxy-2-[18F]fluoro-D-glucose Positron Emission Tomography/Computed Tomography (FDG PET/CT) in the management of prostate cancer (PCa) patients is increasingly recognised. However, its clinical role is still controversial. Many published studies showed that FDG PET/CT might have a prognostic value in the metastatic...
Uploaded on: February 4, 2024 -
2023 (v1)Publication
Introduction: Breast cancer is the most commonly diagnosed malignancy during pregnancy. Breast cancer during pregnancy is a challenging clinical condition requiring proper and timely multidisciplinary management. Areas covered: This review focuses on the management of breast cancer during pregnancy with a focus about the current...
Uploaded on: September 11, 2024 -
2022 (v1)Publication
Multigene germline panel testing is recommended for Pancreatic Cancer (PC) patients; however, for non-BRCA1/2 genes, the clinical utility is unclear. A comprehensive multi-gene assessment in unselected Italian PC patients is missing. We evaluated the prevalence and impact of Pathogenic Variants (PV) in 51 PC susceptibility genes in a real-world...
Uploaded on: February 11, 2024 -
2024 (v1)Publication
Objectives To better understand the type of care offered to Italian patients with advanced breast cancer at the End-of-Life (EoL), we conducted a retrospective observational study. EoL was defined as the period of six months before death.Methods One hundred and twenty-one patients with advanced breast cancer (ABC) treated at IRCCS San Martino...
Uploaded on: July 6, 2024